Orthopedic indications are one of the most common reasons that people may seek or be directed to stem cell therapy. These include joint stiffness, instability, and pain associated with athletic injuries, repetitive use injuries, and osteoarthritis-related dysfunction. Do stem cells work on knees? The answer to this question is uncertain. Some patients treated with stem
Among the clinical applications considered for adult tissue stem cell therapy, relief of chronic pain is a major focus of investigation. The potential mechanisms for pain relief are not thought to be the tissue renewal properties of injected stem cells. Instead, the treatment basis is a hypothesis that tissue stem cells are able to produce
Asymmetrex’s SACK Technology Makes Adult Tissue Stem Cell Genetic Engineering a Simple Reality By providing highly enriched populations of tissue-specific adult stem cells, Asymmetrex’s SACK technology makes direct adult tissue stem cell engineering practical for the first time. With SACK agent supplementation, cultures of SACK strains have stem cell fractions that range from 20% to
Research on perinatal and postnatal tissue stem cells continues to be very active worldwide. Perinatal stem cells are stem cells found in tissues associated with birth, like in the placenta, umbilical cord, and the amniotic fluid that surrounds babies when they are developing in the uterus. Postnatal stem cells are found in the body after
Does Counting Adult Tissue Stem Cells Have a Human Impact? Asymmetrex’s 3-month campaign to increase awareness of the adult tissue stem cell counting problem has focused on how its AlphaSTEM technology solution could impact research and clinical practice. Now, the final post in the series answers the question, “Does counting adult tissue stem cells have
“Leukemia” is a dreaded thing to be told after bringing your child to the doctor because she has become inexplicably tired with a cold that just won’t go away. In the U.S., every year, more than 5000 families hear this cancer name. Thanks to many years of research and clinical investigation, though the treatments are
On March 22, Boston stem cell medicine technology start-up Asymmetrex will present a free, public, online webinar with the goal of discussing how it developed a stem cell technology that has been needed since the beginnings of stem cell biology. Hosted by RegMedNet, a London-based social media network for regenerative medicine professionals, the webinar will
In a RegMedNet post today (March 9, 2016), Asymmetrex explains that, although much attention is given to molecular genetics advances in the efficiency and integrity of new technologies for gene therapy, failure to count tissue stem cells is likely to limit future treatment success. Sufficient genetic engineering and transplantation of targeted tissue stem cells, like
Cliches abound to describe the “unique” properties of adult tissue stem cells. The lay publications of the National Institutes of Health are full of them. “Self-renew.” “Differentiate.” “Multipotent.” The problem with lazy cliches is that they often understate and distort the calming and terrifying beauty of life. The life of adult stem cells is no
With its recently described improved technologies for specifically identifying adult tissue stem cells or detecting their function by a computer simulation technology, biotech start-up Asymmetrex is anticipating a need for rules to move the field of stem cell biology from a past of common errors and misconceptions to a future of exact quantification. Asymmetrex’s 5